Infectious Disease Research, Infection Prevention & Hospital Epidemiology

Philip-Robinson-MD-FIDSA

Dr. Philip Robinson is board certified by the American Board of Internal Medicine in Infectious Disease with over 27 years of experience. Dr. Robinson currently serves as the Medical Director of Infection Prevention and Hospital Epidemiology, as well as the Chair of the Antimicrobial Stewardship Programs at Hoag Memorial Hospital Presbyterian and Hoag Orthopedic Institute in Orange County, California.

He is focusing on infection prevention and clinical research related to the development of therapeutics and vaccinations, serving as the principal investigator for over 25 infectious disease related clinical trials.

Research & Publications

The current COVID-19 crisis has brought rapid change to all our lives. Dr. Robinson has found himself front-and-center of the COVID-19 response and has been focusing on infection prevention and clinical research related to the development of COVID-19 therapeutics and vaccinations.

Education

Infectious Disease Fellowship, 1993 - 1995

University of Southern California/LAC+USC Medical Center

Internal Medicine Internship and Residency, 1990-1993

Harbor - UCLA Medical Center

Medical School, 1985-1990

Michigan State University College of Human Medicine

Certifications & Honors

ABIM Certified Diplomat in Infectious Disease, 1996—2026

SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long Term Care Certificate Course, Atlanta, Georgia, May 2016

SHEA/CDC Training Courses in Healthcare Epidemiology, 1996, 2009, 2015, 2022

Lean Green Belt Certificate, Institute of Industrial Engineers, 2012

Affiliations

Infectious Disease Association of California (Past President), 2018 - Present

Infectious Disease Association of California (Governing Board), 2011 - Present

Infectious Disease Association of California (Member), 1998 - Present

Infectious Disease Society of America, 1994 - Present

Society for Healthcare Epidemiology of America, 1994 - Present

COVID-19 Outpatient Clinical Trial

Now Enrolling Outpatients for a Clinical Trial

Working together with ACTIV‑6 to help people with COVID-19 feel better faster.